Zpredicta Overview

  • Founded

  • 2014

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 5

Employees
  • Latest Deal Type

  • M&A

  • Latest Deal Amount

  • $9.6M

Zpredicta General Information

Description

Provider of an organ specific platform intended to reconstruct physiologically relevant organ-specific human microenvironment of the human bone marrow. The company's organ specific platform creates cell-based biological models that predicts how drugs will behave in the human body and it represents the 3-dimensional microenvironment of human organs critical for successful drug development, enabling drug development companies to rapidly identify drug candidates that will be effective in patients.

Contact Information

Website
www.zpredicta.com
Formerly Known As
Ixchel Scientific
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Healthcare Services
Other Industries
Biotechnology
Parent Company
Predictive Oncology
Primary Office
  • 5941 Optical Court
  • San Jose, CA 95138
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zpredicta Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 24-Nov-2021 $9.6M 00000 00.00 Completed Generating Revenue
3. Angel (individual) 00000 Completed Startup
2. Accelerator/Incubator 18-Aug-2015 $120K $120K 00.000 Completed Startup
1. Accelerator/Incubator 04-Feb-2015 Completed Startup
To view Zpredicta’s complete valuation and funding history, request access »

Zpredicta Patents

  • 9

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Zpredicta Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190169562-A1 Screening of immuno-modulatory therapies Inactive 29-Jul-2016 000000000
CA-2937245-A1 Method and apparatus for isolating invasive and metastatic cells for evaluating therapeutics and prediction of metastatic capacity Inactive 22-Jan-2014 000000000
US-11124756-B2 Method and apparatus for isolating invasive and metastatic cells for evaluating therapeutics and prediction of metastatic capacity Active 22-Jan-2014 000000000 0
US-20160340635-A1 Method and apparatus for isolating invasive and metastatic cells for evaluating therapeutics and prediction of metastatic capacity Active 22-Jan-2014 000000000
AU-2015209434-A1 Method and apparatus for isolating invasive and metastatic cells for evaluating therapeutics and prediction of metastatic capacity Inactive 22-Jan-2014 C12M41/46
To view Zpredicta’s complete patent history, request access »

Zpredicta Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zpredicta Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Beth McClendon Angel (individual) Minority 000 0000 000000 0
Keiko Iwaisako Angel (individual) Minority 000 0000 000000 0
San Jose BioCube Accelerator/Incubator 000 0000 000000 0
Y Combinator Accelerator/Incubator Minority 000 0000 000000 0
To view Zpredicta’s complete investors history, request access »

Ready to get started?

Request a free trial